Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs
Over the past 15 years, University of Alabama at Birmingham endocrinologist Anath Shalev, M.D., has unraveled a crucial biological pathway that malfunctions in diabetes.
Nov 7, 2017
0
5